The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, randomized phase III study of gilteritinib versus salvage chemotherapy in relapsed or refractory FLT3 mutation-positive acute myeloid leukemia.
 
Alexander E. Perl
Honoraria - Novartis
Consulting or Advisory Role - Ambit BioSciences; Arog; Astellas Pharma; Daiichi Sankyo
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)
 
Stephen Anthony Strickland
Honoraria - Astellas Pharma
Consulting or Advisory Role - Alexion Pharmaceuticals; Baxalta; Boehringer Ingelheim; CTI; Daiichi Sankyo; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Research Funding - Boehringer Ingelheim (Inst); Sunesis Pharmaceuticals (Inst)
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - ARIAD; Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Andreas Neubauer
No Relationships to Disclose
 
Giovanni Martinelli
Consulting or Advisory Role - ARIAD; Celgene; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Tomoki Naoe
Stock and Other Ownership Interests - Amgen Astellas BioPharma
Honoraria - Alexion Pharmaceuticals; Amgen Astellas BioPharma; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Nippon Boehringer Ingelheim; Otsuka; Sysmex
Consulting or Advisory Role - Fujifilm (Inst)
Research Funding - Astellas Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Nippon Boehringer Ingelheim (Inst); Otsuka (Inst); Pfizer (Inst); Symex (Inst); Toyama Chemical Co (Inst)
Patents, Royalties, Other Intellectual Property - Chugai Pharma; Fujifilm; Kyowa Hakko Kirin
 
Arnaud Pigneux
Honoraria - Adgen; Celgene; MSD; Novartis
Consulting or Advisory Role - Idem Healthcare
Travel, Accommodations, Expenses - Adgen; Jazz Pharmaceuticals; Pfizer
 
Philippe H. Rousselot
No Relationships to Disclose
 
Christoph Röllig
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Roche; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen; Novartis; Takeda
Research Funding - Bayer
Travel, Accommodations, Expenses - Amgen; Celgene; Gilead Sciences; Janssen
 
Maria R. Baer
No Relationships to Disclose
 
Richard A. Larson
Consulting or Advisory Role - Amgen; ARIAD; Bristol-Myers Squibb; Celgene; CVS Caremark; Jazz Pharmaceuticals; Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst)
 
Angela Joubert James
Employment - Astellas Pharma
Stock and Other Ownership Interests - Celgene
Patents, Royalties, Other Intellectual Property - Celgene
 
Caroline Chen
Employment - Astellas Pharma
 
Lei Shu
Employment - Abbvie; Astellas Pharma
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie; Astellas Pharma
 
Nahla Hasabou
Employment - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Erkut Bahceci
Employment - Astellas Pharma